Summary of Amendments Submitted to the Rules Committee for H.R. 2851 - Stop the Importation and Trafficking of Synthetic Analogues Act of 2017

Summaries Derived from Information Provided by Sponsors

Listed in Alphabetical Order

June 12, 2018 3:48 PM

Click on sponsor for amendment text

Adams (NC)

#14

LATE Requires the Attorney General to consult the American Chemical Society and International Union of Pure and Applied Chemistry when making determinations of drug equivalencies.

Adams (NC)

#15

LATE REVISED Requires the Attorney General to consider the conclusions of a Section 201(b) analysis conducted by the Secretary of HHS in any scheduling determination.

Biggs (AZ)

#11

Removes the AG’s authority to permanently schedule a substance on Schedule A; requires an imminent hazard to public safety for scheduling temporarily; and limits the temporary scheduling authority to 2 years instead of 5.

Connolly (VA)

#8

Restores the Drug Enforcement Agency’s authority to suspend a pharmaceutical distributor’s license to stop suspicious shipments of prescription drugs.

Griffith (VA), Raskin (MD), Jackson Lee (TX)

#1

REVISED Incorporates an inter-agency agreement transmitted to Congress by the Office of National Drug Control Policy (ONDCP), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Justice (DOJ). Specifically, the amendment clarifies when the Attorney General can temporarily and permanently schedule a drug or substance to the newly created schedule A and prevents the Attorney General from permanently scheduling that drug or substance if the Secretary of HHS determines that there is not sufficient potential for abuse. The amendment also clarifies under what circumstances an applicant for a schedule A registration may continue to conduct research with such schedule A substance while their application is pending, among their research accommodations.

Jackson Lee (TX)

#4

Strikes sentencing commission provision.

Jackson Lee (TX)

#5

Criminalizes managers and leaders of criminal activity

Jackson Lee (TX)

#9

Ensures penalties for schedule A controlled substance may not be ordered to run consecutively.

Jackson Lee (TX)

#16

LATE REVISED Strikes mandatory minimum terms of supervised release

Keating (MA)

#12

LATE Repeals Public Law 114–145, which compromised the ability of the DEA to swiftly act to combat unsafe opioid distribution.

Maloney, Sean (NY)

#6

REVISED Requires the Drug Enforcement Administration to make available a report on controlled substance analogues sold by means of the internet.

Norcross (NJ)

#2

Requires 30% of funds collected from fines in this bill are authorized to go towards the Bureau of Justice Assistance’s Residential Substance Abuse Treatment for State Prisoners Program.

Norcross (NJ)

#3

Requires 30% of funds collected from fines in this bill are authorized to go towards substance use disorder treatment programs within the federal Bureau of Prisons.

Pocan (WI), Gosar (AZ), Polis (CO)

#10

Prevents the Secretary from placing a natural botanical substance under new Scheduling authority, and would require Secretary to use existing scheduling proceedings under the Controlled Substances Act, if supported by existing medical and scientific facts.

Polis (CO), Correa (CA)

#7

Requires the VA to study medicinal marijuana as an alternative treatment option to prescription opioids.

Thornberry (TX)

#13

LATE Specifies the factors to determine whether a controlled substance analogue is intended for human consumption, thus making it easier for law enforcement and health officials to take action against synthetic drug manufacturers, distributors, and sellers.